219 related articles for article (PubMed ID: 37242247)
1. An Ethanol Extract of
Kim A; Baek SJ; Shin S; Lee SY; Chung SK
Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid selectively eliminates teratogenic human-induced pluripotent stem cells via apoptotic cell death.
Kim A; Lee SY; Chung SK
Phytomedicine; 2022 Jul; 102():154144. PubMed ID: 35537368
[TBL] [Abstract][Full Text] [Related]
3. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
Kim A; Lee SY; Seo CS; Chung SK
Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
[TBL] [Abstract][Full Text] [Related]
4. Elimination of Teratogenic Human Induced Pluripotent Stem Cells by Bee Venom via Calcium-Calpain Pathway.
Kim A; Lee SY; Kim BY; Chung SK
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380745
[TBL] [Abstract][Full Text] [Related]
5. Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis.
Kim A; Lee SY; Seo CS; Chung SK
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182802
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
7. Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy.
Sougawa N; Miyagawa S; Fukushima S; Kawamura A; Yokoyama J; Ito E; Harada A; Okimoto K; Mochizuki-Oda N; Saito A; Sawa Y
Sci Rep; 2018 Feb; 8(1):3726. PubMed ID: 29487310
[TBL] [Abstract][Full Text] [Related]
8. Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation.
Pellegrini S; Zamarian V; Landi E; Cospito A; Lombardo MT; Manenti F; Citro A; Schiavo Lena M; Piemonti L; Sordi V
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077097
[TBL] [Abstract][Full Text] [Related]
9. The tumourigenicity of iPS cells and their differentiated derivates.
Liu Z; Tang Y; Lü S; Zhou J; Du Z; Duan C; Li Z; Wang C
J Cell Mol Med; 2013 Jun; 17(6):782-91. PubMed ID: 23711115
[TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
[TBL] [Abstract][Full Text] [Related]
11. Direct
Xiang M; Lu M; Quan J; Xu M; Meng D; Cui A; Li N; Liu Y; Lu P; Kang X; Wang X; Sun N; Zhao M; Liang Q; Le L; Wang X; Zhang J; Chen S
Theranostics; 2019; 9(1):290-310. PubMed ID: 30662568
[TBL] [Abstract][Full Text] [Related]
12. Identification of marker genes to monitor residual iPSCs in iPSC-derived products.
Lemmens M; Perner J; Potgeter L; Zogg M; Thiruchelvam S; Müller M; Doll T; Werner A; Gilbart Y; Couttet P; Martus HJ; Libertini S
Cytotherapy; 2023 Jan; 25(1):59-67. PubMed ID: 36319564
[TBL] [Abstract][Full Text] [Related]
13. Efficient, Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase-Mediated Aggregation of Synthetic Peptides.
Kuang Y; Miki K; Parr CJC; Hayashi K; Takei I; Li J; Iwasaki M; Nakagawa M; Yoshida Y; Saito H
Cell Chem Biol; 2017 Jun; 24(6):685-694.e4. PubMed ID: 28529132
[TBL] [Abstract][Full Text] [Related]
14. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
15. Using induced pluripotent stem cell-derived conditional medium to attenuate the light-induced photodamaged retina of rats.
Chang HM; Hung KH; Hsu CC; Lin TC; Chen SY
J Chin Med Assoc; 2015 Mar; 78(3):169-76. PubMed ID: 25557467
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
[TBL] [Abstract][Full Text] [Related]
17. Suspension culture improves iPSC expansion and pluripotency phenotype.
Cuesta-Gomez N; Verhoeff K; Dadheech N; Dang T; Jasra IT; de Leon MB; Pawlick R; Marfil-Garza B; Anwar P; Razavy H; Zapata-Morin PA; Jickling G; Thiesen A; O'Gorman D; Kallos MS; Shapiro AMJ
Stem Cell Res Ther; 2023 Jun; 14(1):154. PubMed ID: 37280707
[TBL] [Abstract][Full Text] [Related]
18. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
[TBL] [Abstract][Full Text] [Related]
19. Progress in preclinical research on induced pluripotent stem cell therapy for acute myocardial infarction.
Cai S; Dai Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 53(2):244-253. PubMed ID: 38594961
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cell-Derived Conditioned Medium Attenuates Acute Kidney Injury by Downregulating the Oxidative Stress-Related Pathway in Ischemia-Reperfusion Rats.
Tarng DC; Tseng WC; Lee PY; Chiou SH; Hsieh SL
Cell Transplant; 2016; 25(3):517-30. PubMed ID: 26132529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
